Healgen Scientific, LLC. products

The Alpha-Fetoprotein (AFP) Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of AFP in whole blood, serum or plasma to aid in the diagnosis of Hepatocellular Carcinoma or fetal open neural tube defects. Alpha-Fetoprotein (AFP) is normally produced during fetal and neonatal development by the liver, yolk sac and in small concentrations by the gastrointestinal tract. By the second year of life, AFP concentrations decrease rapidly, and thereafter only trace amounts are normally detected in serum. In general, normal adults have serum AFP concentrations of less than 10 ng/mL. Elevated AFP levels occur in several malignant diseases including hepatocellular carcinoma, testicular nonseminomatous origin, and occasionally of other entodermal origin. AFP has also been used to detect early tumors in people at high risk for liver cancer. 

The CEA Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of CEA in whole blood, serum or plasma. It is intended as an aid in the assessment and diagnosis of colorectal cancer and other types of cancer, such as pancreatic, stomach, breast, lung and certain types of thyroid and ovarian cancer. The CEA rapid test device utilizes a combination of colloidal gold conjugate and monoclonal antibodies to selectively detect elevated levels of CEA. CEA is present in high concentrations during fetal development, but ceases after birth. Therefore, it is not usually present in the blood of healthy adults. The normal CEA range for a non-smoking adult is less than 2.5 ng/mL and less than 5.0 ng/mL in a smoker.